Healthcare / Health Information ServicesTokyo
$2537.00
-33.00 (-1.28%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $999.2M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$29.1B
P/E
9.8x
↓EV/EBITDA
8.9x
↓ROE
24.1%
↑Gross Margin
57.8%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+19.9%
FCF CAGR
—
FCF margin
-63.7%
FCF / Net income
-3.50x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.20B · net income $2.03B · FCF $-7.13B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.20B | $11.20B | $8.72B | $7.42B | $6.49B |
| Net Income | $2.03B | $2.03B | $870.9M | $391.5M | $515.6M |
| EBITDA | $2.97B | $2.97B | $2.35B | $1.68B | $1.51B |
| EPS | 180.63 | 180.63 | 84.00 | 42.64 | 47.39 |
| Gross Margin | 57.8% | 57.8% | 56.6% | 54.9% | 52.0% |
| Operating Margin | 17.4% | 17.4% | 15.7% | 14.1% | 11.0% |
| Net Margin | 18.2% | 18.2% | 10.0% | 5.3% | 7.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.85 | 0.05 | — |
| Current Ratio | 1.94 | 1.94 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-7.13B | $-7.13B | $999.2M | $1.57B | $2.58B |
| Returns | |||||
| ROE | 24.1% | 24.1% | 13.7% | 14.5% | 21.0% |
| Valuation | |||||
| P/E | 9.77 | 9.77 | 16.58 | — | — |
| EV/EBITDA | 8.94 | 8.94 | 2.24 | — | — |
| P/B | 3.38 | 3.38 | 2.27 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 28.4% | 28.4% | 17.5% | 14.4% | — |
| EPS Growth | 115.0% | 115.0% | 97.0% | -10.0% | — |
| Dividend Yield | 1.6% | 1.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
7.6%
EPS terminal req.
$225.12
Spread vs growth
107.4%
5Y implied EPS CAGR
8.6%
EPS terminal req.
$272.39
Spread vs growth
106.5%
10Y implied EPS CAGR
9.3%
EPS terminal req.
$438.69
Spread vs growth
105.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+5.7%
Start / end P/E
29.0x → 14.0x
EPS bridge
84.00 → 180.63
Residual
-59.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.